Panbela Therapeutics, Inc. - FORM 8-K - EX-16.1 - LETTER FROM MANTYLA MCREYNOLDS LLC - September 11, 2015

Attached files

file filename
EX-4.1 - SPECIMEN STOCK CERTIFICATE - Panbela Therapeutics, Inc.cimarron_ex41.htm
EX-3.2 - COMPOSITE BYLAWS - Panbela Therapeutics, Inc.cimarron_ex32.htm
EX-4.3 - FORM OF WARRANT TO PURCHASE SHARES OF STOCK - Panbela Therapeutics, Inc.cimarron_ex43.htm
EX-4.2 - FORM OF CONVERTIBLE PROMISSORY NOTE - Panbela Therapeutics, Inc.cimarron_ex42.htm
EX-14.1 - CODE OF ETHICS - Panbela Therapeutics, Inc.cimarron_ex141.htm
EX-10.5 - STANDARD EXCLUSIVE LICENSE AGREEMENT - Panbela Therapeutics, Inc.cimarron_ex105.htm
EX-10.2 - FORM OF INCENTIVE STOCK OPTION AGREEMENT - Panbela Therapeutics, Inc.cimarron_ex102.htm
8-K - FORM 8-K - Panbela Therapeutics, Inc.cimarron_8k.htm
EX-99.2 - CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Panbela Therapeutics, Inc.cimarron_ex992.htm
EX-99.3 - PRO FORMA FINANCIAL STATEMENTS - Panbela Therapeutics, Inc.cimarron_ex993.htm
EX-21.1 - LIST OF SUBSIDIARIES - Panbela Therapeutics, Inc.cimarron_ex211.htm
EX-3.1 - COMPOSITE AMENDED AND RESTATED ARTICLES OF INCORPORATION - Panbela Therapeutics, Inc.cimarron_ex31.htm
EX-99.1 - CONSOLIDATED FINANCIAL STATEMENTS - Panbela Therapeutics, Inc.cimarron_ex991.htm
EX-10.1 - STOCK OPTION PLAN - Panbela Therapeutics, Inc.cimarron_ex101.htm
EX-10.3 - FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT - Panbela Therapeutics, Inc.cimarron_ex103.htm
EX-10.4 - INDEMNIFICATION AGREEMENT - Panbela Therapeutics, Inc.cimarron_ex104.htm

EXHIBIT 16.1

 

September 11, 2015

 

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

 

We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred on September 4, 2015, to be filed by our former client, Cimarron Medical, Inc. We agree with the statements made in response to that Item insofar as they relate to our Firm.

 

We have no basis to agree or disagree with the other statements included in such Form 8-K.

 

Very truly yours,

 

/s/ Mantyla McReynolds, LLC

Panbela Therapeutics, Inc. Reports